tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALKS Stock Latest News

Alkermes price target raised to $38 from $37 at Baird
The FlyAlkermes price target raised to $38 from $37 at Baird
2d ago
ALKS
Alkermes price target raised to $37 from $35 at H.C. Wainwright
PremiumThe Fly
Alkermes price target raised to $37 from $35 at H.C. Wainwright
2d ago
ALKS
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
PremiumThe Fly
Alkermes reports Q2 non-GAAP EPS 70c, consensus 70c
3d ago
ALKS
Is ALKS a Buy, Before Earnings?
PremiumPre-Earnings
Is ALKS a Buy, Before Earnings?
5d ago
ALKS
Alkermes price target lowered to $31 from $32 at JPMorgan
PremiumThe Fly
Alkermes price target lowered to $31 from $32 at JPMorgan
12d ago
ALKS
Jefferies says Neurocrine, Alkermes not seeing Sublocade-like impact on Medicaid
PremiumThe FlyJefferies says Neurocrine, Alkermes not seeing Sublocade-like impact on Medicaid
17d ago
ALKS
INDV
Alkermes initiated with a Buy at TD Cowen
PremiumThe Fly
Alkermes initiated with a Buy at TD Cowen
1M ago
ALKS
Alkermes orexin 2 receptor story ignored by investors, says Jefferies
PremiumThe Fly
Alkermes orexin 2 receptor story ignored by investors, says Jefferies
2M ago
ALKS
Alkermes presents data from phase 1b study of ALKS 2680
PremiumThe Fly
Alkermes presents data from phase 1b study of ALKS 2680
2M ago
ALKS
Alkermes Shareholders Approve Board Changes and Stock Plan
PremiumCompany Announcements
Alkermes Shareholders Approve Board Changes and Stock Plan
2M ago
8K
ALKS
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
PremiumThe Fly
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
2M ago
ALKS
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
PremiumThe Fly
Alkermes price target raised to $48 from $43 at Cantor Fitzgerald
2M ago
ALKS
Alkermes backs FY24 financial outlook
PremiumThe FlyAlkermes backs FY24 financial outlook
3M ago
ALKS
Alkermes reports Q1 adjusted EPS 43c, consensus 58c
PremiumThe Fly
Alkermes reports Q1 adjusted EPS 43c, consensus 58c
3M ago
ALKS
Alkermes plc Reports First Quarter 2024 Financial Results
PremiumPress Releases
Alkermes plc Reports First Quarter 2024 Financial Results
3M ago
ALKS
Alkermes plc Reports First Quarter 2024 Financial Results
PremiumPress Releases
Alkermes plc Reports First Quarter 2024 Financial Results
3M ago
ALKS
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
ALKS
Alkermes initiates Phase 2 clinical trial of ALKS 2680
PremiumThe Fly
Alkermes initiates Phase 2 clinical trial of ALKS 2680
3M ago
ALKS
Alkermes price target lowered to $23 from $25 at UBS
PremiumThe Fly
Alkermes price target lowered to $23 from $25 at UBS
3M ago
ALKS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
CUE
PTN
Alkermes narcolepsy drug ‘could be best-in-class,’ says Mizuho
PremiumThe Fly
Alkermes narcolepsy drug ‘could be best-in-class,’ says Mizuho
4M ago
ALKS
Alkermes price target raised to $50 at Jefferies after ‘excellent’ NT2 data
PremiumThe Fly
Alkermes price target raised to $50 at Jefferies after ‘excellent’ NT2 data
4M ago
ALKS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >